Immunization is which type of prevention?
An early expanding stage is denoted by?
Which vaccine is administered via the subcutaneous route?
Contacts of sputum-positive tuberculosis patients who should be given preventive chemotherapy?
The Framingham Heart Study is a type of which epidemiological study?
What is the best epidemiological tool for the investigation of hepatitis B?
The Human Development Index is measured by all of the following except:
What is the mode of prevention in Coronary Heart Disease (CHD)?
Which of the following statements is true about a case-control study?
Which of the following vectors is not resistant to DDT?
Explanation: **Explanation:** **Primary Prevention** aims to prevent the onset of disease by reducing the risk of exposure or increasing resistance to a disease-causing agent. It is applied during the **pre-pathogenesis phase** (before the disease process has started). Immunization is a classic example of **Specific Protection**, which is a mode of intervention under primary prevention. By administering a vaccine, we enhance the individual's immunity to prevent the disease from occurring in the first place. **Why other options are incorrect:** * **Primordial Prevention:** Focuses on preventing the emergence of risk factors (e.g., discouraging children from starting smoking or promoting healthy eating to prevent obesity). Immunization deals with an existing risk of infection. * **Secondary Prevention:** Focuses on **early diagnosis and prompt treatment** (e.g., Pap smears, sputum microscopy for TB). It aims to halt disease progression and prevent complications after the disease process has begun. * **Tertiary Prevention:** Focuses on **disability limitation and rehabilitation** (e.g., physiotherapy after a stroke). It occurs in the late pathogenesis phase to reduce the impact of long-term disease. **High-Yield Clinical Pearls for NEET-PG:** * **Modes of Intervention for Primary Prevention:** 1. Health Promotion (e.g., health education), 2. Specific Protection (e.g., Immunization, Vitamin A prophylaxis, use of helmets). * **Screening tests** are always categorized as **Secondary Prevention**. * **Quaternary Prevention:** A newer concept referring to actions taken to identify patients at risk of over-medicalization and protecting them from unnecessary medical interventions.
Explanation: This question pertains to the **Demographic Cycle**, a model that describes the historical transition of birth and death rates as a country develops. ### 1. Why the Correct Answer is Right In the **Early Expanding Stage (Stage 2)**, the death rate begins to decline significantly due to improvements in sanitation, food supply, and basic healthcare. However, the birth rate remains high and **unchanged** because social norms, religious beliefs, and lack of family planning awareness take longer to evolve. The widening gap between the high birth rate and the falling death rate leads to a rapid increase in the total population (population explosion). ### 2. Analysis of Incorrect Options * **A. Decreased birth rate and decreased death rate:** This describes the **Late Expanding Stage (Stage 3)**. Here, the birth rate finally begins to fall, but the population still grows because the birth rate remains higher than the death rate. * **B. Increased birth rate and increased death rate:** This does not represent any standard stage of the demographic cycle. * **C. Decreased birth rate and increased death rate:** This is biologically and sociologically atypical for a developing population; it would lead to rapid population collapse. ### 3. High-Yield Clinical Pearls for NEET-PG * **Stage 1 (High Stationary):** High birth rate + High death rate (e.g., India in the 1920s). * **Stage 2 (Early Expanding):** High birth rate + Falling death rate (Many African countries are currently here). * **Stage 3 (Late Expanding):** Falling birth rate + Low death rate (India is currently in this stage). * **Stage 4 (Low Stationary):** Low birth rate + Low death rate (e.g., UK, USA). * **Stage 5 (Declining):** Birth rate lower than death rate (e.g., Germany, Japan, Hungary). * **Key Fact:** India is currently in **Stage 3** of the demographic cycle.
Explanation: **Explanation:** The route of administration for vaccines is determined by the immunogenicity and the rate of absorption required for an optimal immune response. **1. Why Measles is Correct:** The **Measles vaccine** (and the combined MMR/MR vaccines) is traditionally administered via the **subcutaneous (SC)** route, usually over the right upper arm. The subcutaneous tissue has fewer blood vessels than muscle, allowing for a slower, more sustained release of the live-attenuated virus, which is essential for developing long-term cellular and humoral immunity. **2. Why the other options are incorrect:** * **BCG (Bacillus Calmette-Guérin):** Administered strictly **Intradermal (ID)** using an Omega/Tuberculin syringe. This is to ensure a local delayed hypersensitivity reaction and the formation of a characteristic permanent scar. * **Rabies (Modern Cell Culture Vaccines):** Administered either **Intramuscular (IM)** in the deltoid muscle (Essen regimen) or **Intradermal (ID)** (Thai Red Cross regimen). It is never given SC as it may result in sub-optimal antibody titers. * **DPT (Diphtheria, Pertussis, Tetanus):** Administered **Intramuscular (IM)** in the anterolateral aspect of the mid-thigh. DPT contains an adjuvant (aluminum salts); if given SC, it can cause severe local irritation, inflammation, and sterile abscesses. **High-Yield Clinical Pearls for NEET-PG:** * **SC Vaccines:** Measles, MMR, Yellow Fever, and Varicella. * **ID Vaccines:** BCG, IPV (fractional dose), and Rabies (IDRV). * **IM Vaccines:** DPT, Pentavalent, Hepatitis B, TT, and PCV. * **Oral Vaccines:** OPV and Rotavirus. * **Site of Injection:** For infants, the preferred IM site is the **Vastus Lateralis** (anterolateral thigh), not the gluteal region, to avoid sciatic nerve injury.
Explanation: **Explanation:** In the context of Tuberculosis (TB) control programs (such as India’s NTEP), **Preventive Chemotherapy (TB Preventive Treatment - TPT)** is aimed at preventing the progression of latent TB infection to active disease. **Why Option A is Correct:** Children **below 6 years** of age who are household contacts of a sputum-positive pulmonary TB patient are at the highest risk of developing severe, disseminated forms of TB (like TB Meningitis or Miliary TB) due to their immature immune systems. Even if they are asymptomatic, they are prioritized for TPT (usually with Isoniazid for 6 months) after ruling out active TB, regardless of their BCG vaccination status or TST/IGRA results. **Analysis of Incorrect Options:** * **B & C (Elderly and Children >6 years):** While these groups can be infected, they are not routinely given universal preventive therapy unless they belong to specific high-risk categories (e.g., living with HIV or on immunosuppressants). In the general population, the risk-benefit ratio for mass TPT in these age groups is lower compared to young children. * **D (Pregnant Women):** Pregnancy is not an independent indication for TPT unless the woman is a close contact of a TB patient AND is also immunocompromised (e.g., HIV positive). **High-Yield Clinical Pearls for NEET-PG:** * **Standard Regimen:** Isoniazid (H) at 5 mg/kg daily for 6 months is the traditional TPT. Newer regimens include 3 months of weekly Rifapentine + Isoniazid (3HP). * **Priority Groups for TPT:** 1. Household contacts <6 years, 2. People Living with HIV (PLHIV) of all ages, 3. Immunocompromised patients (e.g., those on anti-TNF alpha therapy or dialysis). * **Prerequisite:** Always rule out **Active TB** (via symptom screening and CXR) before starting TPT to prevent the development of drug-resistant TB.
Explanation: **Explanation:** The **Framingham Heart Study** is the quintessential example of a **Prospective Cohort Study**. Initiated in 1948 in Framingham, Massachusetts, it followed a large group of healthy individuals over several decades to observe the development of cardiovascular diseases. 1. **Why Cohort Study is Correct:** In a cohort study, a group of people (the cohort) is defined based on the presence or absence of exposure to a risk factor and followed forward in time to see who develops the outcome. The Framingham study identified risk factors (smoking, hypertension, high cholesterol) in healthy subjects and monitored them over generations to determine the incidence of heart disease. This "cause-to-effect" approach is the hallmark of a cohort design. 2. **Why other options are incorrect:** * **Case-control study:** This is a retrospective "effect-to-cause" study that starts with diseased individuals (cases) and compares them to those without the disease (controls). * **Cross-sectional study:** This provides a "snapshot" of a population at a single point in time, measuring prevalence rather than incidence. * **Ecological study:** This uses populations or groups as the unit of analysis rather than individuals (e.g., comparing fat consumption and heart disease rates between different countries). **High-Yield Clinical Pearls for NEET-PG:** * **Incidence:** Cohort studies are the best for calculating the **Incidence** of a disease. * **Risk Measurement:** They provide the **Relative Risk (RR)** and **Attributable Risk (AR)**. * **Framingham Legacy:** This study coined the term **"Risk Factor"** and established the link between physical inactivity, obesity, and CAD. * **Generations:** It is currently in its third generation of participants (Original, Offspring, and Third Generation cohorts).
Explanation: **Explanation:** In the epidemiological investigation of Hepatitis B, the goal is to identify individuals who have been infected at any point in time (past or present). **Anti-HBc (Antibody to Hepatitis B core antigen)** is the best tool for this purpose because it is the most reliable marker of exposure to the actual virus. **Why Anti-HBcAg is the correct answer:** * **Marker of Infection:** Unlike other markers, Anti-HBc is produced only in response to an actual infection with the Hepatitis B virus (HBV). It is not produced by vaccination. * **Persistence:** Once developed, Anti-HBc (specifically IgG) persists for life. This makes it the ideal "serological scar" to determine the true prevalence of HBV in a community. * **The Window Period:** During the "window period" (when HBsAg has disappeared but Anti-HBs has not yet appeared), Anti-HBc (IgM) is the only detectable marker of acute infection. **Why other options are incorrect:** * **Anti-HBsAg:** This indicates immunity. However, it cannot distinguish between immunity gained from a natural infection and immunity gained from **vaccination**. Therefore, it overestimates the spread of the virus in vaccinated populations. * **Anti-HBeAg:** This is a marker of reduced viral replication and low infectivity. It is used for prognosis and monitoring, not for screening or primary epidemiological surveys. * **HBcAg:** This is an intracellular antigen found within hepatocytes. It does not circulate freely in the blood and is therefore not used as a diagnostic or epidemiological tool in serum. **High-Yield NEET-PG Pearls:** * **Total Anti-HBc:** Best marker for epidemiological prevalence (indicates past or present infection). * **IgM Anti-HBc:** Best marker for diagnosing **acute** Hepatitis B (and the only marker positive in the window period). * **HBsAg:** First marker to appear in blood; indicates current infection (acute or chronic). * **HBeAg:** Best indicator of **high infectivity** and active viral replication.
Explanation: The **Human Development Index (HDI)** is a composite statistical tool used by the UNDP to measure a country's social and economic development. It is based on three core dimensions, each represented by specific indicators. ### Why "Under-five mortality rate" is the correct answer: The **Under-five mortality rate** is an indicator used in the **Physical Quality of Life Index (PQLI)**, not the HDI. While it reflects child health, the HDI uses "Life expectancy at birth" as the sole indicator for the health dimension. ### Explanation of Incorrect Options (Components of HDI): * **Life Expectancy at Birth (Option B):** This represents the **Health** dimension. It is the only health-related metric used in HDI calculation. * **Literacy Rate (Option C):** This represents the **Education** dimension. It is measured by a combination of *Mean years of schooling* (for adults) and *Expected years of schooling* (for children). * **Per Capita Income (Option D):** This represents the **Standard of Living** dimension. It is specifically measured as **Gross National Income (GNI) per capita** at Purchasing Power Parity (PPP) in US Dollars. ### High-Yield NEET-PG Pearls: * **HDI vs. PQLI:** * **HDI:** Life expectancy at birth, Education, GNI per capita. (Range: 0 to 1). * **PQLI:** Infant mortality rate, Life expectancy at age 1, Literacy rate. (Range: 0 to 100). * **Key Distinction:** PQLI does **not** include economic/income measures, whereas HDI does. * **Current Trend:** India currently falls under the "Medium Human Development" category. * **Calculation:** HDI is the **Geometric Mean** of the three dimension indices.
Explanation: ### Explanation **Why Primordial Prevention is Correct:** Primordial prevention is defined as the prevention of the **emergence or development of risk factors** in population groups where they have not yet appeared. In the context of Coronary Heart Disease (CHD), the primary risk factors are lifestyle-related (e.g., smoking, obesity, sedentary lifestyle, and high salt intake). Since CHD is a "lifestyle disease," the most effective long-term strategy is to discourage these habits through individual and mass education *before* the risk factors develop. This is considered the "best" mode of prevention for non-communicable diseases (NCDs) like CHD. **Analysis of Incorrect Options:** * **High-risk Strategy (A):** This is a form of **Primary Prevention** that focuses on individuals already at high risk (e.g., those with hypertension or high cholesterol). It aims to prevent the *onset* of disease but does not prevent the *emergence* of the risk factor itself. * **Secondary Prevention (C):** This involves **early diagnosis and prompt treatment** (e.g., using statins or aspirin in a patient already diagnosed with CHD) to prevent complications or recurrence. * **Tertiary Prevention (D):** This focuses on **disability limitation and rehabilitation** (e.g., cardiac rehabilitation after a myocardial infarction) to improve quality of life and reduce impairment. **NEET-PG High-Yield Pearls:** * **Primordial Prevention** is the hallmark of NCD control (CHD, Hypertension, Type 2 Diabetes). * **Primary Prevention** (General population/High-risk) aims to reduce *incidence*. * **Secondary Prevention** aims to reduce *prevalence* by shortening the duration of disease. * **Quaternary Prevention** (Bonus): Actions taken to identify patients at risk of over-medicalization and protect them from unnecessary medical interventions.
Explanation: **Explanation:** A **Case-Control Study** is an observational, analytical study design that proceeds from "effect to cause." It compares a group of individuals with a disease (cases) to a group without the disease (controls) to look for past exposure to risk factors. **Why Option B is Correct:** Case-control studies are inherently **rapid and inexpensive** because the outcome (disease) has already occurred. Researchers do not need to wait for years for the disease to develop (unlike cohort studies). Data is collected from existing records or interviews, making it the most efficient design for studying diseases with long latency periods or rare diseases. **Why the Other Options are Incorrect:** * **Option A:** Case-control studies can study **multiple exposures** for a single outcome, but **not multiple outcomes**. Cohort studies are used to study multiple outcomes from a single exposure. * **Option C:** Case-control studies are **highly prone to bias**, particularly **Recall Bias** (cases remember exposures differently than controls) and **Selection Bias** (Berksonian bias). * **Option D:** Since it is an observational study based on historical data or interviews, there is **no intervention** involved; therefore, it carries no physical risk to the subjects. **High-Yield NEET-PG Pearls:** * **Direction:** Retrospective (Backwards in time). * **Measure of Association:** **Odds Ratio (OR)**. * **Best for:** Rare diseases and diseases with long latent periods. * **First Step:** Selection of cases and controls. * **Matching:** Done to eliminate the effect of confounding variables.
Explanation: **Explanation:** The correct answer is **Phlebotomus** (Sandfly). **1. Why Phlebotomus is the correct answer:** In the field of medical entomology, resistance to insecticides is a major challenge. **Phlebotomus argentipes** (the vector for Kala-azar) remains remarkably susceptible to **DDT** (Dichlorodiphenyltrichloroethane) in most parts of the world, including India. This susceptibility is the primary reason why **Indoor Residual Spraying (IRS)** with DDT remains the cornerstone of the National Kala-azar Elimination Programme. **2. Analysis of Incorrect Options:** * **Musca domestica (Housefly):** This was one of the first insects to develop widespread resistance to DDT shortly after its introduction in the 1940s. Their rapid breeding cycle and high exposure levels led to metabolic and target-site resistance. * **Culex mosquito:** *Culex quinquefasciatus* (the vector for Bancroftian Filariasis) is notorious for its high level of resistance to organochlorines like DDT and even many organophosphates, often due to its habitat in polluted water. * **Anopheles stephensi:** This is the primary urban malaria vector in India. It has developed widespread resistance to DDT, BHC, and Malathion, necessitating the use of synthetic pyrethroids in many regions. **High-Yield Clinical Pearls for NEET-PG:** * **Kala-azar Control:** DDT is the insecticide of choice for IRS in the Kala-azar elimination program, applied at a dosage of **0.25 g/m²** (unlike Malaria, where it is 1 g/m²). * **Sandfly Characteristics:** They are 1/4th the size of a mosquito, hop rather than fly, and are nocturnal. * **Resistance Mechanism:** Resistance to DDT in mosquitoes is often mediated by the **kdr (knock-down resistance)** gene mutation or increased activity of **GST (Glutathione S-transferases)** enzymes.
Principles of Epidemiology
Practice Questions
Measures of Disease Frequency
Practice Questions
Epidemiological Study Designs
Practice Questions
Descriptive Epidemiology
Practice Questions
Analytical Epidemiology
Practice Questions
Experimental Epidemiology
Practice Questions
Screening for Disease
Practice Questions
Surveillance Systems
Practice Questions
Investigation of an Epidemic
Practice Questions
Association and Causation
Practice Questions
Modern Epidemiological Methods
Practice Questions
Critical Appraisal of Epidemiological Studies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free